Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
PIMJETMI® (pimicotinib) Developed by Abbisko Therapeutics and Licensed by Merck KGaA, Darmstadt, Germany Receive U.S. FDA Approval for TGCT 2026-11-11 12:05
NEC Returns to Singapore Fintech Festival with AI-Powered Financial Services Solutions 2026-11-10 14:00
TPEx Successfully Concludes 2026 Forum on Building New Core of Asian Bond Markets 2026-11-06 19:12
NCCN and Viet Nam National Cancer Hospital Expand Collaboration to Advance Cancer Care Resources in Vietnam 2026-11-05 10:06
PAQ Therapeutics to Present First Clinical Data for PT0253, a Selective KRAS G12D Degrader, in Late-Breaking Oral Presentation at the 2026 EORTC-NCI-AACR Symposium 2026-11-03 20:00
Laboratoires Pierre Fabre announces the approval of BRAFTOVI® (encorafenib) in combination with MEKTOVI® (binimetinib) for the treatment of adult patients with advanced non-small cell lung cancer with a BRAFV600E mutation in Singapore 2026-11-03 10:00
Sirolimus-Coated Balloon Matches Drug-Eluting Stent at One Year in Large International TRANSFORM II Trial 2026-11-02 21:22
Insira Launches as Independent Company Built on Cortellis and DRG 2026-10-29 20:00
Fox ESS Builds on Residential Success with Expanded C&I Solutions at All Energy Australia 2026 2026-10-29 10:16
Final OS Analysis Results of Phase III OptiTROP-Breast01 Study of Sacituzumab Tirumotecan (sac-TMT) Presented as an ESMO Oral Presentation and Simultaneously Published in Annals of Oncology 2026-10-26 18:33
Innovent Announces NMPA Acceptance of a New Indication Application of Sintilimab for the Treatment of Advanced Melanoma 2026-10-26 17:18
2026 ESMO | Innovent Presents Multiple Clinical Data Updates for IBI363/TAK-928, a PD-1/Alpha-Biased IL-2 Bispecific Fusion Protein 2026-10-26 08:00
The Results of Phase III OptiTROP-Lung06 Study of Sacituzumab Tirumotecan (sac-TMT) Presented as an ESMO Oral Presentation and Simultaneously Published in The New England Journal of Medicine 2026-10-25 18:44
Ascletis' Strategic Partner Sagimet Announces First Patient Dosed in Phase III U.S. Clinical Trial of Denifanstat (ASC40) for Moderate to Severe Acne 2026-10-23 08:10
ImmVira Presents Clinical Data from Three Bladder Cancer Studies at ESMO 2026 2026-10-23 08:00
TraceLink Unveils Chorus to Integrate-Once™ Across Enterprise and Internet Data Sources with MCP or API Access 2026-10-22 22:00
Everest Medicines Appoints Two Veteran mRNA Cancer Vaccine Scientists to Advance Global Clinical Development 2026-10-09 10:15
Lundbeck to showcase progress across its movement disorders pipeline with data in multiple system atrophy and Parkinson's disease at MDS® 2026 2026-10-02 15:05
Akeso Announces First Patient Enrolled in Global Phase III Trial of Cadonilimab Versus Nivolumab in First-Line Gastric Cancer 2026-09-28 10:05
STARTRADER Named Best Fintech Forex Broker at Forex Expo Dubai 2026 2026-09-24 19:03
1 2 3 4 5 9